U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
156151156151Intravenous Fish Oil in Critically Ill Cardiac PatientsCompletedNo Results AvailableCoronary Artery Disease|Myocardial InfarctionDrug: Fish oil emulsion|Drug: normal saline 0.9%https://ClinicalTrials.gov/show/NCT00516178
156152156152RAD001 in Advanced Hepatocellular CarcinomaCompletedNo Results AvailableHepatocellular CarcinomaDrug: RAD001https://ClinicalTrials.gov/show/NCT00516165
156153156153Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCTCompletedNo Results AvailableChronic Myeloid Leukemia|Acute Myelogenous Leukemia|Myelodysplasia|Acute Lymphocytic Leukemia|Severe Aplastic Anemia|Non-Hodgkin's Lymphoma|Lymphoproliferative Disease|Multiple Myeloma|Advanced Myeloproliferative DiseaseDrug: Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSFhttps://ClinicalTrials.gov/show/NCT00516152
156154156154Lamotrigine Extended-Release In Elderly Patients With EpilepsyCompletedHas ResultsEpilepsyDrug: Lamotriginehttps://ClinicalTrials.gov/show/NCT00516139
156155156155Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac SurgeryCompletedNo Results AvailableCoronary Artery Bypass Graft Triple Vessel|Blood Coagulation Disordershttps://ClinicalTrials.gov/show/NCT00516126
156156156156A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual DysphoriaCompletedNo Results AvailablePremenstrual Dysphoric Disorder|Premenstrual SyndromeDrug: paroxetinehttps://ClinicalTrials.gov/show/NCT00516113
156157156157Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLCActive, not recruitingNo Results AvailableNon-small Cell Lung CancerDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00516100
156158156158LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)CompletedNo Results AvailableNasopharyngeal CarcinomaGenetic: Genetically modified CTLshttps://ClinicalTrials.gov/show/NCT00516087
156159156159A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 DiabetesCompletedHas ResultsType 2 Diabetes MellitusDrug: exenatide|Drug: placebohttps://ClinicalTrials.gov/show/NCT00516074
156160156160Relationship of Peritoneal Solute Transport Rate With VEGF in Children Undergoing Peritoneal DialysisRecruitingNo Results AvailablePeritoneal Dialysishttps://ClinicalTrials.gov/show/NCT00516061
156161156161An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 DiabetesCompletedHas ResultsType 2 Diabetes MellitusDrug: exenatidehttps://ClinicalTrials.gov/show/NCT00516048
156162156162Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy AdultsCompletedNo Results AvailableInfluenza|Virus DiseasesBiological: Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca)https://ClinicalTrials.gov/show/NCT00516035
156163156163Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.CompletedNo Results AvailableNon Small Cell Lung CancerDrug: Mistletoe extracthttps://ClinicalTrials.gov/show/NCT00516022
156164156164Efficacy of Intravenous Dexamethasone for Acute Disc Herniation-Induced SciaticaRecruitingNo Results AvailableRADICULAR PAINDrug: DEXAMETHASONE|Other: PLACEBOhttps://ClinicalTrials.gov/show/NCT00516009
156165156165Genetic Abnormalities and Biological Changes of Panic Disorder Patients After PharmacotherapyRecruitingNo Results AvailablePanic Disorderhttps://ClinicalTrials.gov/show/NCT00515996
156166156166Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma CellsCompletedNo Results AvailableMelanomaBiological: DC/Apo-Nechttps://ClinicalTrials.gov/show/NCT00515983
156167156167Curettage Versus Excision in Nodular and Superficial Basal Cell CarcinomasSuspendedNo Results AvailableCarcinoma, Basal CellProcedure: Curettage|Procedure: Deep excision|Procedure: Shave excision|Procedure: Curettagehttps://ClinicalTrials.gov/show/NCT00515970
156168156168Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)WithdrawnNo Results AvailableNASOPHARYNGEAL CARCINOMAGenetic: genetically modified CTLs in combo with CD45 antibodieshttps://ClinicalTrials.gov/show/NCT00515957
156169156169Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A ProductsCompletedNo Results AvailableHealthyDrug: Botulinum neurotoxin type A, free of complexing proteinshttps://ClinicalTrials.gov/show/NCT00515944
156170156170Radiation Therapy as Palliative Treatment of GISTCompletedNo Results AvailableSarcomaRadiation: Radiation therapy (external beam photons)https://ClinicalTrials.gov/show/NCT00515931
156171156171The Effect of Early Iron Deficiency on Developmental Brain and Behavior in InfantsNot yet recruitingNo Results AvailableIron DeficiencyDietary Supplement: ironhttps://ClinicalTrials.gov/show/NCT00515918
156172156172One-lung Ventilation: Expression of Pulmonary Inflammatory MediatorsCompletedNo Results AvailableThoracic Surgery With One-lung VentilationDrug: Sevoflurane/propofolhttps://ClinicalTrials.gov/show/NCT00515905
156173156173Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance DiseaseRecruitingNo Results AvailableLeukemia|Non-Hodgkin's Lymphoma|NHLDrug: Immunotoxin therapy|Drug: CAT-8015 Immunotoxin|Procedure: Biological therapy|Procedure: Antibody Therapy|Procedure: Monoclonal Antibody Therapyhttps://ClinicalTrials.gov/show/NCT00515892
156174156174Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social PhobiaCompletedHas ResultsSocial Anxiety DisorderDrug: D-cycloserine|Behavioral: Cognitive behavioral therapy (CBT)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00515879
156175156175Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic CancerCompletedNo Results AvailablePancreatic NeoplasmsDrug: KU-0059436 (AZD2281)(PARP inhibitor)|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00515866
156176156176The Role of Biofeedback in Improving Continence After Anterior ResectionRecruitingNo Results AvailableRectal Neoplasms|Fecal Incontinence|AgedBehavioral: Biofeedbackhttps://ClinicalTrials.gov/show/NCT00515853
156177156177GPIAG and Leicester Asthma and Dysfunctional Breathing (GLAD) Study: a Randomised Controlled StudyActive, not recruitingNo Results AvailableAsthma|Dysfunctional BreathingOther: Physiotherapisthttps://ClinicalTrials.gov/show/NCT00515840
156178156178Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral LoadCompletedHas ResultsHIV InfectionsDrug: Raltegravir (MK-0518)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00515827
156179156179Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptorsCompletedNo Results AvailableRetinitis PigmentosaDevice: Retina implant is surgically placed into subretinal positionhttps://ClinicalTrials.gov/show/NCT00515814
156180156180Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DMCompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: glibenclamide|Drug: placebohttps://ClinicalTrials.gov/show/NCT00515801

* Görseller ve İçerik tekif hakkına sahip olabilir